Martin-Grace Julie, Tomkins Maria, O'Reilly Michael W, Sherlock Mark
Department of Endocrinology, Royal College of Surgeons in Ireland, Dublin, Ireland.
Department of Endocrinology, Beaumont Hospital, Dublin, Ireland.
Nat Rev Endocrinol. 2024 Apr;20(4):209-227. doi: 10.1038/s41574-023-00929-x. Epub 2024 Jan 25.
Iatrogenic adrenal insufficiency (IAI) is the most common form of adrenal insufficiency in adult patients, although its overall exact prevalence remains unclear. IAI is associated with adverse clinical outcomes, including adrenal crisis, impaired quality of life and increased mortality; therefore, it is imperative that clinicians maintain a high index of suspicion in patients at risk of IAI to facilitate timely diagnosis and appropriate management. Herein, we review the major causes, clinical consequences, diagnosis and care of patients with IAI. The management of IAI, particularly glucocorticoid-induced (or tertiary) adrenal insufficiency, can be particularly challenging, and the provision of adequate glucocorticoid replacement must be balanced against minimizing the cardiometabolic effects of excess glucocorticoid exposure and optimizing recovery of the hypothalamic-pituitary-adrenal axis. We review current treatment strategies and their limitations and discuss developments in optimizing treatment of IAI. This comprehensive Review aims to aid clinicians in identifying who is at risk of IAI, how to approach screening of at-risk populations and how to treat patients with IAI, with a focus on emergency management and prevention of an adrenal crisis.
医源性肾上腺功能不全(IAI)是成年患者中最常见的肾上腺功能不全形式,尽管其确切的总体患病率仍不清楚。IAI与不良临床结局相关,包括肾上腺危象、生活质量受损和死亡率增加;因此,临床医生必须对有IAI风险的患者保持高度怀疑指数,以便及时诊断和适当管理。在此,我们综述了IAI患者的主要病因、临床后果、诊断和护理。IAI的管理,尤其是糖皮质激素诱导的(或三级)肾上腺功能不全,可能特别具有挑战性,必须在提供足够的糖皮质激素替代治疗与尽量减少糖皮质激素过量暴露的心脏代谢影响以及优化下丘脑-垂体-肾上腺轴的恢复之间取得平衡。我们综述了当前的治疗策略及其局限性,并讨论了优化IAI治疗的进展。本综述旨在帮助临床医生识别哪些人有IAI风险、如何对高危人群进行筛查以及如何治疗IAI患者,重点是紧急管理和预防肾上腺危象。